Factors Associated With Postoperative Opioid Prescribing After Primary Elective Cesarean Section
| Autor: | Krista B. Highland, Kevin L Hammond, Germaine F Herrera, Michael S Patzkowski |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
030219 obstetrics & reproductive medicine Elective cesarean section business.industry Public Health Environmental and Occupational Health Retrospective cohort study General Medicine Pain management Institutional review board Opioid prescribing Adult women 03 medical and health sciences 0302 clinical medicine Opioid Emergency medicine medicine 030212 general & internal medicine Medical prescription business medicine.drug |
| Zdroj: | Military Medicine. 188:e339-e342 |
| ISSN: | 1930-613X 0026-4075 |
| DOI: | 10.1093/milmed/usab263 |
| Popis: | Introduction Guidelines indicate the need to balance the risks of opioid prescribing with the need to adequately manage pain after cesarean section (CS). Although guidelines suggest the need for tailored opioid prescribing, it is unclear whether providers currently tailor opioid prescribing practices given patient-related factors. Thus, research is needed to first understand post-CS pain management and opioid prescribing. The objective of the present study was to identify factors related to CS discharge opioid prescriptions. Material and Methods This retrospective cohort study was approved by the Brooke Army Medical Center Institutional Review Board (San Antonio, Texas; #C.2020.094e) on June 23, 2020. Electronic health record data of healthy adult women undergoing primary elective CS, performed under regional neuraxial anesthesia at a single, academic, tertiary medical center from 2018 to 2019, were included. Multivariable regression examined patient and medical factors associated with post-CS opioid prescriptions. Results In the present sample (N = 169), 23% (n = 39) of patients did not use opioids postoperatively, while inpatient and almost all of those patients (n = 36) received a discharge prescription for opioids with a median amount of 225 morphine milligram equivalent doses. There was a lack of evidence indicating that patient and medical factors were associated with discharge opioid dose. Conclusion Patient and medical factors were not associated with post-CS opioid prescribing. Larger studies are needed to better elucidate optimal post-CS pain management in the days and months that follow CS. Such findings are needed to better tailor opioid prescribing, consistent with clinical practice guidelines. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|